Enfermedades pulmonares en pacientes infectados con VIH hospitalizados en el Instituto Nacional del Tórax

Background: Pulmonary diseases are common among HIV infected patients. The prevalence of the different diseases varies greatly. Aim: To identify the different pulmonary diseases that affect a Chilean population of HIV infected patients and to identify factors associated with in hospital mortality. Material and methods: Retrospective review of the clinical records of all HIV infected patients with lung diseases discharged from our institution during a period of 3.5 years. Collection of demographic and biomedical data. Results: One hundred seventy one patients (aged 35.7 years, 86% men) had 236 episodes of lung diseases. Only 13.5% of the patients were receiving antiretroviral therapy and 18% were on pneumocystis prophylaxis. Infectious diseases accounted for 87% of the discharges, neoplasm for 5.1%. Pneumocystis jirovecii infection was responsible for 37.7% of the episodes, community acquired pneumonia was seen in 24.1% and mycobacterial diseases in 14.4%. Two or more conditions were present in 13.6%. Death during hospital stay occurred in 19.5%. Multivariate analysis identified pneumothorax as the only significant independent predictor of in-hospital mortality in patients with pneumocystis pneumonia, while nosocomial pneumonia was the only predictor of death among patients with non-pneumocystis pulmonary diseases. Conclusions: Infectious diseases were the main cause of hospitalization among Chilean HIV infected patients. Mortality among these patients remains high. Appropriate antiretroviral therapy and prophylaxis may alter pulmonary disease prevalence in the future. Every effort should be made to avoid the development of pneumothorax and nosocomial pneumonia

Saved in:
Bibliographic Details
Main Authors: Chernilo S,Sara, Trujillo V,Sergio, Kahn Ch,Mariana, Paredes P,Mónica, Echevarría O,Ghislaine, Sepúlveda L,Claudia
Format: Digital revista
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2005
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000500002
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-98872005000500002
record_format ojs
spelling oai:scielo:S0034-988720050005000022005-06-17Enfermedades pulmonares en pacientes infectados con VIH hospitalizados en el Instituto Nacional del TóraxChernilo S,SaraTrujillo V,SergioKahn Ch,MarianaParedes P,MónicaEchevarría O,GhislaineSepúlveda L,Claudia Antiretroviral therapy HIV Lung diseases Respiratory tract infections Background: Pulmonary diseases are common among HIV infected patients. The prevalence of the different diseases varies greatly. Aim: To identify the different pulmonary diseases that affect a Chilean population of HIV infected patients and to identify factors associated with in hospital mortality. Material and methods: Retrospective review of the clinical records of all HIV infected patients with lung diseases discharged from our institution during a period of 3.5 years. Collection of demographic and biomedical data. Results: One hundred seventy one patients (aged 35.7 years, 86% men) had 236 episodes of lung diseases. Only 13.5% of the patients were receiving antiretroviral therapy and 18% were on pneumocystis prophylaxis. Infectious diseases accounted for 87% of the discharges, neoplasm for 5.1%. Pneumocystis jirovecii infection was responsible for 37.7% of the episodes, community acquired pneumonia was seen in 24.1% and mycobacterial diseases in 14.4%. Two or more conditions were present in 13.6%. Death during hospital stay occurred in 19.5%. Multivariate analysis identified pneumothorax as the only significant independent predictor of in-hospital mortality in patients with pneumocystis pneumonia, while nosocomial pneumonia was the only predictor of death among patients with non-pneumocystis pulmonary diseases. Conclusions: Infectious diseases were the main cause of hospitalization among Chilean HIV infected patients. Mortality among these patients remains high. Appropriate antiretroviral therapy and prophylaxis may alter pulmonary disease prevalence in the future. Every effort should be made to avoid the development of pneumothorax and nosocomial pneumoniainfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.133 n.5 20052005-05-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000500002es10.4067/S0034-98872005000500002
institution SCIELO
collection OJS
country Chile
countrycode CL
component Revista
access En linea
databasecode rev-scielo-cl
tag revista
region America del Sur
libraryname SciELO
language Spanish / Castilian
format Digital
author Chernilo S,Sara
Trujillo V,Sergio
Kahn Ch,Mariana
Paredes P,Mónica
Echevarría O,Ghislaine
Sepúlveda L,Claudia
spellingShingle Chernilo S,Sara
Trujillo V,Sergio
Kahn Ch,Mariana
Paredes P,Mónica
Echevarría O,Ghislaine
Sepúlveda L,Claudia
Enfermedades pulmonares en pacientes infectados con VIH hospitalizados en el Instituto Nacional del Tórax
author_facet Chernilo S,Sara
Trujillo V,Sergio
Kahn Ch,Mariana
Paredes P,Mónica
Echevarría O,Ghislaine
Sepúlveda L,Claudia
author_sort Chernilo S,Sara
title Enfermedades pulmonares en pacientes infectados con VIH hospitalizados en el Instituto Nacional del Tórax
title_short Enfermedades pulmonares en pacientes infectados con VIH hospitalizados en el Instituto Nacional del Tórax
title_full Enfermedades pulmonares en pacientes infectados con VIH hospitalizados en el Instituto Nacional del Tórax
title_fullStr Enfermedades pulmonares en pacientes infectados con VIH hospitalizados en el Instituto Nacional del Tórax
title_full_unstemmed Enfermedades pulmonares en pacientes infectados con VIH hospitalizados en el Instituto Nacional del Tórax
title_sort enfermedades pulmonares en pacientes infectados con vih hospitalizados en el instituto nacional del tórax
description Background: Pulmonary diseases are common among HIV infected patients. The prevalence of the different diseases varies greatly. Aim: To identify the different pulmonary diseases that affect a Chilean population of HIV infected patients and to identify factors associated with in hospital mortality. Material and methods: Retrospective review of the clinical records of all HIV infected patients with lung diseases discharged from our institution during a period of 3.5 years. Collection of demographic and biomedical data. Results: One hundred seventy one patients (aged 35.7 years, 86% men) had 236 episodes of lung diseases. Only 13.5% of the patients were receiving antiretroviral therapy and 18% were on pneumocystis prophylaxis. Infectious diseases accounted for 87% of the discharges, neoplasm for 5.1%. Pneumocystis jirovecii infection was responsible for 37.7% of the episodes, community acquired pneumonia was seen in 24.1% and mycobacterial diseases in 14.4%. Two or more conditions were present in 13.6%. Death during hospital stay occurred in 19.5%. Multivariate analysis identified pneumothorax as the only significant independent predictor of in-hospital mortality in patients with pneumocystis pneumonia, while nosocomial pneumonia was the only predictor of death among patients with non-pneumocystis pulmonary diseases. Conclusions: Infectious diseases were the main cause of hospitalization among Chilean HIV infected patients. Mortality among these patients remains high. Appropriate antiretroviral therapy and prophylaxis may alter pulmonary disease prevalence in the future. Every effort should be made to avoid the development of pneumothorax and nosocomial pneumonia
publisher Sociedad Médica de Santiago
publishDate 2005
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000500002
work_keys_str_mv AT chernilossara enfermedadespulmonaresenpacientesinfectadosconvihhospitalizadosenelinstitutonacionaldeltorax
AT trujillovsergio enfermedadespulmonaresenpacientesinfectadosconvihhospitalizadosenelinstitutonacionaldeltorax
AT kahnchmariana enfermedadespulmonaresenpacientesinfectadosconvihhospitalizadosenelinstitutonacionaldeltorax
AT paredespmonica enfermedadespulmonaresenpacientesinfectadosconvihhospitalizadosenelinstitutonacionaldeltorax
AT echevarriaoghislaine enfermedadespulmonaresenpacientesinfectadosconvihhospitalizadosenelinstitutonacionaldeltorax
AT sepulvedalclaudia enfermedadespulmonaresenpacientesinfectadosconvihhospitalizadosenelinstitutonacionaldeltorax
_version_ 1755988160950566912